📰 Priority Review News
Page 63 - Priority Review News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Priority Review. Real-time updates on events, politics, business and more.
April 21, 2023
LianBio Announces China National Medical Products Administration Acceptance with Priority Review of New Drug Application for Mavacamten for the Treatment of... | April 21, 2023
April 19, 2023
The FDA granted a priority review to Lonsurf with or without Avastin for the treatment of patients with pretreated metastatic colorectal cancer.
April 18, 2023
The U.S. Food and Drug Administration approved Gamida Cell Ltd.'s Omisirge (omidubicel-onlv) cell therapy for patients with blood cancers to reduce risk of infection following stem cell transplantation.
April 18, 2023
SILVER SPRING, Md., April 17, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the
April 18, 2023
/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...
April 18, 2023
The Food and Drug Administration granted botensilimab plus balstilimab a Fast Track Designation to treat certain patients with metastatic colorectal cancer.
April 18, 2023
The FDA has accepted for priority review the supplemental new drug application seeking the approval of trifluridine/tipiracil as a single agent or in combination with bevacizumab for use in select patients with refractory, metastatic colorectal cancer.
April 17, 2023
Clinical-stage immuno-oncology company Agenus Inc. (GEN) Monday said the US Food and Drug Administration has granted Fast Track Designation for the investigation of the combination of botensilimab (AGEN1181) and balstilimab (AGEN2034).
April 17, 2023
FDA approves Omisirge (omidubicel-onlv), a nicotinamide modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery time of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection following stem cell transplantation.
April 17, 2023
Agenus Inc. , a leading immuno-oncology company specializing in immunological agents for cancer and infectious diseases, has been granted Fast Track Designation from the US Food and Drug... | April 17, 2023